Chief Executive Officer and Founder
Greg founded Morgan Prestwich in 2010 following a highly successful career in Biopharmaceutical Executive Search. His driver was to create a firm, based on a sound moral compass, transparency and business ethics aligned with his own as well as those of clients and candidates. He has become internationally recognised as an expert Advisor and Head Hunter, specialising in helping small to medium sized US or Japanese headquartered Biopharmaceutical businesses to build their operations in Europe & US.
Greg is a competitive sportsman interested in cricket, rugby, golf and skiing. He is also a keen investor in a variety of global businesses. Greg is a true family man, married to Emma for 12 years with 3 young extremely active sporty boys!
He supports a local charity ‘Love Works’ by allocating space at Morgan Prestwich’s UK offices. The charity help people who have fallen on hard times get back on their feet by giving food, clothing and general support counselling.
The Advisory Practice is led by Greg Bell, supported by Sean Morgan-Jones, whose combined experience delivers unique insights into the opportunities and pitfalls associated with building operations beyond the comfort of company Headquarters. They offer practical advice, based on real-world experience on how best to execute this strategy, and ranges from the huge variation in employment contracts – particularly across Europe – to the timing and phasing of any roll-out by functional area.
Our established relationships with key Governmental representatives in the major European centres, help inform decisions on where to best locate European Headquarters in order to take best advantage of both regional incentives and the Biopharma talent pool.
We have strategic partners to support our advisory service right across the full spectrum when launching new products. These partners cover a wide and diverse spectrum including Market Access/Pricing, Regulatory, Medical, Legal, Research, Communications, Governments, Training, HR, Payroll and Investors.
Led by our Client Partner, Georgia Attwood, the clinical development team support clients from Pre-Clinical through clinical phases I to III. We strengthen Boards and Leadership teams to develop their science in preparation for commercialisation or acquisition. We work with true start-up Biotech companies in rare, orphan, and speciality diseases, where science can have a real impact on patient lives.
Board, C-suite, Leadership
Great science deserves great teams and great teams need exceptional leadership. This applies right across the whole value chain from Drug Development through to Commercialisation, and getting the right leadership team in place early is a critical success factor. We have an enviable track record of advising and building top Boards and Leadership teams globally, spearheaded by CEO and Founder, Greg Bell, ably supported Sean Morgan-Jones (CCO) and Client Partner Mark Budd.
Delivering ground breaking medical innovation to a patient’s bedside relies on the expertise of professionals in Leadership, Product Launch, Market Access, Marketing and Sales, and these are core to our heritage. Led by our client Partner, Mark Budd, and supported closely by CEO, Greg Bell, our commercialisation practice has extensive global networks which deliver an A Class team alongside your A Class medicine.